XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 2,981 $ 3,456
Trade accounts receivable, net 11,528 7,902
Inventories, net 21,591 23,952
Prepaid expenses and other current assets 1,528 1,892
Total current assets 37,628 37,202
Property, plant and equipment, net 4,963 5,366
Operating lease right-of-use (ROU) assets 1,358 1,560
Investments 0 742
Deferred tax assets, net 4,116 4,116
Capitalized product development cost 430 0
Other assets 388 422
Total assets 48,883 49,408
Current liabilities:    
Accounts payable 8,785 9,822
Accrued compensation and related taxes 1,629 1,302
Accrued warranty expense 807 722
Accrued other expenses and other current liabilities 544 363
Short-term operating lease liabilities 551 525
Credit facility 3,659 6,476
Notes payable-current portion 0 71
Deferred revenue 1,355 1,137
Total current liabilities 17,330 20,418
Long-term operating lease liabilities 1,002 1,260
Deferred revenue 7,145 6,419
Total liabilities 25,477 28,097
Stockholders' equity:    
Preferred stock; $1.00 par value; 1,000,000 authorized shares; none issued or outstanding 0 0
Common stock; $0.60 par value; 10,000,000 authorized shares; 3,877,798 and 3,867,082 issued and 3,535,718 and 3,577,002 outstanding shares as of June 30, 2024 and December 31, 2023, respectively 2,327 2,320
Additional paid-in capital 48,996 48,602
Accumulated deficit (21,864) (24,209)
Treasury stock, at cost, 342,080 and 290,080 shares as of June 30, 2024, and December 31, 2023, respectively (6,053) (5,402)
Total stockholders' equity 23,406 21,311
Total liabilities and stockholders' equity $ 48,883 $ 49,408